Our People

Protecting the company’s reputation and trust

LEARN MORE

Welcome to the global
corporate site for Takeda.

If you are looking for specific information,
please visit our country/region website.




 

 

SELECT A COUNTRY OR REGION SITE

Unveiling Takeda's inaugural Access to Medicines Report
LEARN MORE

Stepping up the fight to end HIV, TB and malaria among women and children
LEARN MORE

Please wait...

Topics

Takeda Chair in Global Child Health at the London School of Hygiene & Tropical Medicine (LSHTM)
LEARN MORE

TAKEDA LIFE THEATER
LEARN MORE

Quarterly Announcements
LEARN MORE

2019 Innovators in Science Award Winners Celebrated for Regenerative Medicine Research
LEARN MORE

Information

A Statement of Confidence in the Leadership of Mr. Christophe Weber and Comments on the Proposals at the 143rd Ordinary General Meeting of Shareholders from Masahiro Sakane, the Chair of the Board of Directors Meeting of Takeda

143rd Ordinary General Meeting of Shareholders (10:00 am JST on June 27, 2019)

Place: PACIFICO Yokohama, National Convention Hall

FY2018 Financial Results Announcement (3:00 pm JST on May 14th, 2019)

Conference Call on Financial Results

For Media: 3:30 pm - 4:15 pm JST

For Investors & Analysts: Part 1 5:00 pm - 6:30 pm JST, Part 2 9:00 pm - 10:00 pm JST

Presenters: Christophe Weber, President & CEO, and others

Offer for Shire plc

ADS Helpline

Copyright 1995-2019 Takeda Pharmaceutical Company Limited. All rights reserved.